ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Clinical diagnosis of stroke subtypes

Clinical diagnosis of stroke subtypes
Author:
Louis R Caplan, MD
Section Editor:
Scott E Kasner, MD
Deputy Editor:
John F Dashe, MD, PhD
Literature review current through: Jan 2024.
This topic last updated: Jun 28, 2022.

INTRODUCTION — The two broad categories of stroke, hemorrhage and ischemia, are diametrically opposite conditions: hemorrhage is characterized by too much blood within the closed cranial cavity, while ischemia is characterized by too little blood to supply an adequate amount of oxygen and nutrients to a part of the brain [1]. Each of these categories can be divided into subtypes that have somewhat different causes, clinical pictures, clinical courses, outcomes, and treatment strategies. As an example, intracranial hemorrhage can be caused by intracerebral hemorrhage (ICH), also called parenchymal hemorrhage, which involves bleeding directly into brain tissue, and subarachnoid hemorrhage (SAH), which involves bleeding into the cerebrospinal fluid that surrounds the brain and spinal cord [1].

This topic will review the categories of stroke and their clinical diagnosis. An overview of the evaluation of stroke and the clinical manifestations of transient cerebral ischemia are discussed separately. (See "Overview of the evaluation of stroke" and "Definition, etiology, and clinical manifestations of transient ischemic attack".)

The classification of stroke is reviewed here briefly and discussed in detail separately. (See "Stroke: Etiology, classification, and epidemiology".)

CLASSIFICATION — Stroke is classified into the following subtypes: intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and brain ischemia due to thrombosis, embolism, or systemic hypoperfusion.

Brain ischemia — The three main subtypes of brain ischemia are thrombosis, embolism, and hypoperfusion.

Thrombosis generally refers to local in situ obstruction of an artery. The obstruction may be due to disease of the arterial wall, such as arteriosclerosis, dissection, or fibromuscular dysplasia; there may or may not be superimposed thrombosis. Thrombotic strokes can be divided into either large or small vessel disease (table 1). These two subtypes of thrombosis are worth distinguishing since the causes, outcomes, and treatments are different. Atherosclerosis is by far the most common cause of in situ local disease within the large extracranial and intracranial arteries that supply the brain.

In patients with thrombosis, the neurologic symptoms often fluctuate, remit, or progress in a stuttering fashion (figure 1). (See 'Clinical course of symptoms and signs' below and "Definition, etiology, and clinical manifestations of transient ischemic attack".)

Embolism refers to particles of debris originating elsewhere that block arterial access to a particular brain region. Embolic strokes may arise from a source in the heart, aorta, or large vessels (table 1). The embolus suddenly blocks the recipient site so that the onset of symptoms is abrupt and usually maximal at the start (figure 2). Unlike thrombosis, multiple sites within different vascular territories may be affected when the source is the heart (eg, left atrial appendage or left ventricular thrombus) or aorta.

Systemic hypoperfusion is a more general circulatory problem, manifesting itself in the brain and perhaps other organs. Reduced cerebral blood flow is more global in patients with systemic hypoperfusion and does not affect isolated regions. Symptoms of brain dysfunction typically are diffuse and nonfocal in contrast to the other two categories of ischemia. The neurologic signs are typically bilateral, although they may be asymmetric when there is preexisting asymmetrical craniocerebral vascular occlusive disease.

Intracerebral hemorrhage — Bleeding in ICH is usually derived from arterioles or small arteries. The bleeding is directly into the brain, forming a localized hematoma that spreads along white matter pathways. Accumulation of blood occurs over minutes or hours and the neurologic symptoms usually increase gradually over minutes or a few hours. In contrast to brain embolism and SAH, the neurologic symptoms do not begin abruptly and are not maximal at onset (figure 3).

Subarachnoid hemorrhage — Rupture of an aneurysm releases blood directly into the cerebrospinal fluid (CSF) under arterial pressure. The blood spreads quickly within the CSF, rapidly increasing intracranial pressure. Death or deep coma ensues if the bleeding continues. The bleeding usually lasts only a few seconds but rebleeding is very common. With causes of SAH other than aneurysm rupture, the bleeding is less abrupt and may continue over a longer period of time.

Symptoms of SAH begin abruptly in contrast to the more gradual onset of ICH. The sudden increase in pressure causes a cessation of activity (eg, loss of memory or focus or knees buckling). Headache is an invariable symptom and is typically instantly severe and widespread. There are usually no important focal neurologic signs unless bleeding occurs into the brain and CSF at the same time (meningocerebral hemorrhage).

Onset headache is more common in SAH than in ICH, whereas the combination of onset headache and vomiting is infrequent in ischemic stroke (figure 4).

DISTINGUISHING STROKE SUBTYPES — Many findings of the history and physical examination suggest certain stroke subtypes (table 2). This presumptive clinical diagnosis requires confirmation by brain and vascular imaging. (See "Overview of the evaluation of stroke".)

Clinical course of symptoms and signs — The most important historical item for differentiating stroke subtypes is the pace and course of the symptoms and signs and their clearing [1]. Each subtype has a characteristic course [2].

Embolic strokes most often occur suddenly (figure 2). The deficits indicate focal loss of brain function that is usually maximal at onset. Rapid recovery also favors embolism.

Thrombosis-related symptoms often fluctuate, varying between normal and abnormal or progressing in a stepwise or stuttering fashion with some periods of improvement (figure 1).

Penetrating artery occlusions usually cause symptoms that develop during a short period of time, hours or at most a few days (figure 5), compared with large artery-related brain ischemia, which can evolve over a longer period.

Intracerebral hemorrhage (ICH) does not improve during the early period; it progresses gradually during minutes or a few hours (figure 3).

Aneurysmal subarachnoid hemorrhage (SAH) develops in an instant. Focal brain dysfunction is less common.

Patients often do not give a specific history regarding the course of neurologic symptoms. It is useful to ask if the patient could walk, talk, use the phone, use the hand, etc, as the events developed after the first symptoms occurred [1].

Neurologic worsening after acute ischemic stroke is not uncommon. In a large prospective study, neurologic deterioration during the acute phase (48 to 72 hours from onset) of cerebral ischemia occurred in 256 (13 percent) of 1964 patients [3]. Deterioration was related mainly to progressive infarction, increased intracranial pressure, recurrent cerebral ischemia, and secondary parenchymal hemorrhage. Independent predictors of neurologic deterioration included the following:

Internal carotid artery occlusion

Brainstem infarction

Middle cerebral artery M1 segment occlusion

Territorial infarction

Diabetes mellitus

Silent brain infarcts — Silent brain infarcts (ie, silent strokes) are infarcts identified only by neuroimaging. There is no accompanying clinical history of stroke or TIA. However, this relationship is somewhat clouded because a more detailed history may elicit symptoms to suggest that a lesion is not truly silent [4]. In addition, these lesions seem to be associated with cognitive deficits [5,6]. Therefore, it is more appropriate to refer to these clinically unrecognized lesions as covert brain infarcts.

Patients with TIA and minor stroke appear to have a high risk of covert infarcts as well as clinically symptomatic infarcts. This point is illustrated by a study of 143 hospital patients with TIA or minor stroke [7]. On follow-up at 30 days, the risk of new ischemic lesions on magnetic resonance imaging (MRI) diffusion-weighted imaging or fluid-attenuated inversion recovery (FLAIR) sequences was approximately 10 percent, and nearly half of these new lesions were asymptomatic [7].

Covert brain infarction may be more common than symptomatic stroke [8]. In a population-based cross-sectional survey of 267 older adult community residents in Germany, the prevalence of silent stroke was 12.7 percent [9]; the presence of silent stroke was associated with diminished cognitive performance in the domain of procedural speed. Patients with severe atherosclerotic disease may have silent infarcts at younger ages than those without such disease burden [10].

In the Cardiovascular Health Study, 1433 participants with no brain infarcts on a baseline head MRI scan had a repeat head MRI at five years [5]. One or more infarcts were detected in 18 percent of subjects, and these MRI defined infarcts were typically:

Single infarcts (76 percent)

Small (3 to 20 mm in 87 percent)

Subcortical (80 percent)

Without acute symptoms recognized as a TIA or stroke (89 percent)

Furthermore, these covert infarcts were associated with subtle cognitive change. Subjects with MRI defined infarcts had a significantly greater decline on the Modified Mini-Mental State Examination and Digit Symbol Substitution test than those without infarcts at follow-up. The severity of white matter changes on initial MRI was the strongest predictor of new infarcts.

Covert infarcts may have important prognostic implications for stroke risk and cognitive decline. In the Rotterdam Scan Study, patients with silent brain infarcts were at significantly increased risk for subsequent stroke (adjusted hazard ratio 3.9) [11]. Patients with more than one silent infarct were at higher risk than those with one silent infarct, and patients with more white matter lesions were also at increased risk for subsequent stroke. In another report from the Rotterdam Scan Study, the presence of silent brain infarcts significantly increased the risk of dementia (hazard ratio 2.26) [6]. The presence of silent brain infarcts on the baseline MRI was associated with decreased performance on neuropsychological tests and a steeper decline in global cognitive function.

Ecology and risk factors — Ecology refers to known demographic and historical features that provide probabilities of the patient having one or more of the stroke subtypes. The presence of these risk factors increase the odds that a stroke is due to a particular mechanism, but the clinician cannot make a firm diagnosis simply on the basis of probability.

As examples: some conditions such as hypertension predispose to more than one subtype (thrombosis, ICH); the presence of a prior myocardial infarction increases the likelihood of cardiac origin embolism, but also increases the likelihood of carotid and vertebral artery neck occlusive disease (thrombosis); and an older patient with severe atherosclerosis may also harbor an unexpected cerebral aneurysm.

Age, sex, and race — Age, sex, and race are important demographic variables known to the clinician before taking the history [2].

Most thrombotic and embolic strokes related to atherosclerosis occur in older patients. Individuals under age 40 rarely have severe atherosclerosis unless they also have important risk factors such as diabetes, hypertension, hyperlipidemia, smoking, or a strong family history. In contrast, hemorrhages (both ICH and SAH) are common in adolescents and young adults [12]. Cardiac-origin embolism is also common in young people who are known to have heart disease.

Hypertensive ICH is more common among Black and Asian individuals than among White individuals.

Premenopausal women have a lower frequency of atherosclerosis than men of similar age unless they have major stroke risk factors. While data are limited, stroke prevalence may be increasing in women aged 45 to 54 years [13].

Black and Asian populations, and adult females have a lower incidence of occlusive disease of the extracranial carotid and vertebral arteries than adult White males [14-16].

Small vessel strokes, strokes of undetermined origin and large vessel strokes are more common among Black people compared with White people. (See "Stroke: Etiology, classification, and epidemiology", section on 'Epidemiology'.)

Heart disease — Heart disease, including atrial fibrillation, valvular disease, recent myocardial infarction, and endocarditis, increases the probability of a stroke due to embolism (table 3) [17]. Of these, atrial fibrillation is the most prominent, causing nearly half of all cardioembolic strokes. The risk of stroke appears to be greatly increased after myocardial infarction (MI), particularly in the first 30 days [18,19].

A number of minor cardiac sources of emboli are known but have an uncertain association with stroke. (See "Stroke: Etiology, classification, and epidemiology", section on 'Embolism'.)

Hypertension — Hypertension is the most common and most important stroke risk factor [20,21], including isolated systolic hypertension [22,23]. Epidemiologic studies show that there is a gradually increasing incidence of both coronary disease and stroke as the blood pressure rises above 110/75 mmHg (figure 6) [20,24]. Both prior blood pressure and current blood pressure are important risk factors [25]. However, these observations do not prove a causal relationship, since increasing blood pressure could be a marker for other risk factors such as increasing body weight, which is associated with dyslipidemia, glucose intolerance, and the metabolic syndrome. (See "Metabolic syndrome (insulin resistance syndrome or syndrome X)".)

The best evidence for a causal role of increasing blood pressure in cardiovascular complications is an improvement in outcome with antihypertensive therapy. An overview of 14 hypertension treatment trials concluded that a long-term (mean five years) 5 to 6 mmHg decrease in the usual diastolic blood pressure was associated with a 35 to 40 percent reduction in stroke [21].

Severe uncontrolled hypertension is a strong risk factor for ICH. A young person who enters the hospital with the acute onset of a focal neurologic deficit and a blood pressure greater than 220/120 mmHg has a high likelihood of having an ICH. In a Korean cohort study, for each 20 mmHg increase in systolic blood pressure, the increased relative risk for hemorrhagic stroke was greater than that for ischemic stroke (3.18 versus 2.23) [26]. For blood pressures great than 180/110 mmHg, the difference in relative risk was even more pronounced between hemorrhagic and ischemic stroke subtypes (28.83 versus 9.56).

Chronic hypertension is a risk factor for both thrombotic extracranial and intracranial large artery disease and penetrating artery disease. Conversely, the absence of a history of hypertension or of present hypertension reduces the likelihood of ICH and penetrating artery disease.

Smoking — Smoking increases the likelihood of extracranial occlusive vascular disease, nearly doubling the risk of stroke [27,28]. The risk of ischemic stroke decreases over time after smoking cessation. In one series of middle-aged women, for example, the excess risk among former smokers largely disappeared two to four years after cessation [29].

Other risk factors — Other risk factors for stroke include the following:

Diabetes increases the likelihood of large and small artery occlusive disease and ischemic stroke but has not been shown to predispose to hemorrhagic stroke [30]. However, data from the Nurses' Health Study suggest that type 1 diabetes might also be a risk factor for hemorrhagic stroke [31].

Elevated total cholesterol and decreased high-density lipoprotein cholesterol have been associated with increased risk of ischemic stroke and large artery stroke in some, but not all, studies. This topic is discussed separately. (See "Overview of secondary prevention of ischemic stroke", section on 'Dyslipidemia'.)

Elevated serum lipoprotein(a) has been associated with intracranial [32], extracranial [33], and aortic [34] large artery occlusive disease.

The use of amphetamines increases the likelihood of both ICH and SAH but not brain ischemia. Many younger individuals who suffer an ICH following amphetamine use have an underlying vascular lesion such as an aneurysm or arteriovenous malformation [35].

Cocaine-related strokes are often hemorrhagic (ICH and SAH), due to hypertensive surges and aneurysms [36]. Cocaine is also associated with brain ischemia, especially involving the posterior circulation intracranial arteries; this is probably due to vasoconstriction [37]. (See "Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse", section on 'Stroke'.)

Stroke during the puerperium has an increased likelihood of being related to venous or arterial thrombosis.

The presence of a known bleeding disorder or prescription of oral anticoagulants predisposes to hemorrhage, into either the brain or the cerebrospinal fluid.

Phenylpropanolamine in appetite suppressants appears to be an independent risk factor for hemorrhagic stroke (including ICH and SAH) in women, especially in those who take a higher than recommended amount [38].

The link between stroke and oral contraceptive use has been a controversial issue. Initial studies suggesting this association were performed with oral contraceptives containing higher doses of estrogen [39]; the risk may not be as great with current low dose oral contraceptives. (See "Combined estrogen-progestin contraception: Side effects and health concerns".)

Other historical features

Previous transient ischemic attack — A history of transient ischemic attack (TIA), especially more than one, in the same territory as the stroke strongly favors the presence of a local vascular lesion (thrombosis). Attacks in more than one vascular territory suggest brain embolism from the heart or aorta. TIAs are not a feature of brain hemorrhage.

Patients often will not volunteer a prior history of symptoms consistent with a TIA. Many patients, for example, do not relate prior hand or eye problems to subsequent leg problems. Thus, the physician must ask directly about specific symptoms. "Did your arm, hand, or leg ever transiently go numb?" "Did you ever having difficulty speaking?" "Did you ever lose vision? If so, in what part of your vision? Was it in one eye and, if so, which one?"

Activity at the onset or just before the stroke — Hemorrhages (ICH and SAH) can be precipitated by sex or other physical activity, while thrombotic strokes are unusual under these circumstances. Trauma before the stroke suggests traumatic dissection or occlusion of arteries or traumatic brain hemorrhage. Sudden coughing and sneezing sometimes precipitates brain embolism. Similarly, getting up during the night to urinate seems to promote brain embolism (a matutinal embolus). There is a trend toward clustering of ischemic stroke in the morning hours, but insufficient specificity to predict with any reasonable likelihood the stroke subtype according to the circadian pattern of symptom onset [40].

Associated symptoms — The presence of fever, headache, vomiting, seizures, and hypotension are suggestive of specific stroke subtypes.

Fever raises the suspicion of endocarditis and resulting embolic stroke.

Infections activate acute phase blood reactants, thereby predisposing to thrombosis.

Severe headache at the onset of neurologic symptoms favors SAH, while headache that develops after symptom onset that is accompanied by gradually increasing neurologic signs, decreased consciousness, and vomiting is most often indicative of ICH (figure 4). Some patients have headaches in the prodromal period before thrombotic strokes. A prior history of intermittent severe headaches that are instantaneous in onset, persist for days, and prevent daily activities often reflects the presence of an aneurysm.

Vomiting is common in patients with ICH, SAH, and posterior circulation large artery ischemia (figure 4).

Seizures in the acute phase of stroke are most often seen in patients with lobar ICH or brain embolism; they are less common in patients with acute thrombosis [41]. In a population-based study, the incidence of seizures within the first 24 hours of stroke onset for SAH, ICH, and ischemic stroke was 10, 8, and 3 percent, respectively [42].

Reduced alertness favors the presence of hemorrhage. Accompanying neurologic signs are suggestive of ICH, while the absence of focal signs suggests SAH. Reduced consciousness may also occur with thrombotic and embolic strokes that are large or involve the posterior circulation large arteries. In particular, ischemia involving the tegmentum of the pons can cause loss of consciousness. Large hemispheric infarcts are typically followed by edema that can progress to coma.

CLINICAL EVALUATION

General physical examination — Important clues in the general physical examination include the following:

Absent pulses (inferior extremity, radial, or carotid) favors a diagnosis of atherosclerosis with thrombosis, although the sudden onset of a cold, blue limb favors embolism.

The internal carotid arteries in the neck cannot be reliably palpated but, in some patients, occlusion of the common carotid artery in the neck can be diagnosed by the absence of a carotid pulse.

The presence of a neck bruit suggests the presence of occlusive extracranial disease, especially if the bruit is long, focal, and high pitched.

Palpating the facial pulses is helpful in diagnosing common carotid and internal carotid artery occlusions and temporal arteritis. The facial pulses on the side of the occlusion are often lost with common carotid artery occlusions. In contrast, some patients with internal carotid artery occlusion will have increased facial pulses on the side of the occlusion because collateral channels develop between the external carotid artery facial branches and the carotid arteries intracranially.

Cardiac findings, especially atrial fibrillation, murmurs and cardiac enlargement, favor cardiac-origin embolism. (See "Auscultation of cardiac murmurs in adults".)

Careful examination of the optic fundus may reveal a cholesterol crystal, white platelet-fibrin, or red clot emboli. Subhyaloid hemorrhages in the eye suggest a suddenly developing brain or SAH. When the carotid artery is occluded, the iris may appear speckled and the ipsilateral pupil can become dilated and poorly reactive. The retina in that circumstance may also show evidence of chronic ischemia (venous stasis retinopathy).

Neurologic examination — The patient's account of his or her neurologic symptoms and the neurologic signs found on examination tell more about the location of the process in the brain than the particular stroke subtype. Nevertheless, the presence of some constellations of symptoms and signs occasionally suggests a specific process. As examples:

Weakness of the face, arm, and leg on one side of the body unaccompanied by sensory, visual, or cognitive abnormalities (pure motor stroke) favors the presence of a thrombotic stroke involving penetrating arteries or a small ICH.

Large focal neurologic deficits that begin abruptly or progress quickly are characteristic of embolism or ICH.

Abnormalities of language suggest anterior circulation disease, as does the presence of motor and sensory signs on the same side of the body (figure 7).

Vertigo, staggering, diplopia, deafness, crossed symptoms (one side of the face and other side of the body), bilateral motor and/or sensory signs, and hemianopsia suggest involvement of the posterior circulation. (See "Posterior circulation cerebrovascular syndromes".)

The sudden onset of impaired consciousness in the absence of focal neurologic signs is characteristic of SAH. (See 'Clinical course of symptoms and signs' above.)

Neuroimaging — In the evaluation of acute stroke, imaging studies are necessary to identify hemorrhage as a cause of the deficit, and they are useful to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit. Advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients who are likely to benefit from therapy. (See "Neuroimaging of acute stroke".)

Biomarkers — Numerous biomarkers and panels of biomarkers have been studied to improve the early diagnosis of stroke. Two blood biomarkers, NT-proBNP and D-dimer, may have the strongest data to support clinical use in differentiating stroke mechanism, but none have sufficient sensitivity or specificity for routine clinical use. They must be interpreted in the context of the clinical and other laboratory findings. These issues are discussed in greater detail elsewhere. (See "Blood biomarkers for stroke".)

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Stroke in adults".)

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Stroke (The Basics)")

Beyond the Basics topics (see "Patient education: Stroke symptoms and diagnosis (Beyond the Basics)")

SUMMARY

Classification – Stroke is classified into three main subtypes: intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and ischemic stroke. The classification of stroke is discussed in detail separately. (See "Stroke: Etiology, classification, and epidemiology".)

Distinguishing stroke subtypes – Patient demographic variables, the presence of stroke risk factors, and findings from the history and physical examination may suggest certain stroke subtypes (table 2). This presumptive clinical diagnosis requires confirmation by brain and vascular imaging. (See 'Distinguishing stroke subtypes' above.)

Clinical course – The most important historical item for differentiating stroke subtypes is the pace and course of the symptoms and signs and their clearing. Embolic strokes most often occur suddenly (figure 2). Thrombosis-related symptoms often fluctuate (figure 1). Penetrating artery occlusions usually cause symptoms that develop during a short period of time, hours or at most a few days (figure 5), whereas large artery-related brain ischemia can evolve over a longer period. Intracerebral hemorrhage (ICH) does not improve during the early period; it progresses gradually during minutes or a few hours (figure 3). Aneurysmal subarachnoid hemorrhage (SAH) develops in an instant. Focal brain dysfunction is less common. (See 'Clinical course of symptoms and signs' above.)

Ecology and risk factors – Ecology refers to known demographic and historical features that provide probabilities of the patient having one or more of the stroke subtypes. The presence of these risk factors increases the odds that a stroke is due to a particular mechanism, but the clinician cannot make a firm diagnosis simply on the basis of probability.

Age, sex, and race (see 'Age, sex, and race' above)

Heart disease and atrial fibrillation (see 'Heart disease' above)

Hypertension (see 'Hypertension' above)

Smoking (see 'Smoking' above)

Hyperlipidemia and diabetes (see 'Other risk factors' above)

Other historical features – A history of transient ischemic attack (TIA), activity just before or at the time of stroke onset, and associated symptoms (eg, fever, severe headache, vomiting, seizure, reduced alertness) are additional features that may favor particular stroke subtypes. (See 'Other historical features' above.)

Clinical evaluation – The general physical examination may provide clues suggesting a particular stroke subtype. As an example, the presence of atrial fibrillation favors embolism from the heart. The symptoms and signs found on neurologic examination tell more about the stroke localization than the particular stroke subtype. However, some constellations of symptoms and signs occasionally suggest a specific process; as an example, unilateral weakness unaccompanied by sensory, visual, or cognitive abnormalities (pure motor stroke) favors the presence of a thrombotic stroke involving penetrating arteries or a small ICH. (See 'Clinical evaluation' above.)

  1. Caplan LR. Basic pathology, anatomy, and pathopysiology of stroke. In: Caplan's Stroke: A Clinical Approach, 4th edition, Saunders Elsevier, Philadelphia 2009. p.22.
  2. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986; 17:648.
  3. Weimar C, Mieck T, Buchthal J, et al. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005; 62:393.
  4. Saini M, Ikram K, Hilal S, et al. Silent stroke: not listened to rather than silent. Stroke 2012; 43:3102.
  5. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002; 33:2376.
  6. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348:1215.
  7. Coutts SB, Hill MD, Simon JE, et al. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 2005; 65:513.
  8. Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis 2003; 16:280.
  9. Schmidt WP, Roesler A, Kretzschmar K, et al. Functional and cognitive consequences of silent stroke discovered using brain magnetic resonance imaging in an elderly population. J Am Geriatr Soc 2004; 52:1045.
  10. Giele JL, Witkamp TD, Mali WP, et al. Silent brain infarcts in patients with manifest vascular disease. Stroke 2004; 35:742.
  11. Vermeer SE, Hollander M, van Dijk EJ, et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 2003; 34:1126.
  12. Marini C, Totaro R, De Santis F, et al. Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke 2001; 32:52.
  13. Towfighi A, Saver JL, Engelhardt R, Ovbiagele B. A midlife stroke surge among women in the United States. Neurology 2007; 69:1898.
  14. Wang MY, Mimran R, Mohit A, et al. Carotid stenosis in a multiethnic population. J Stroke Cerebrovasc Dis 2000; 9:64.
  15. Wolma J, Nederkoorn PJ, Goossens A, et al. Ethnicity a risk factor? The relation between ethnicity and large- and small-vessel disease in White people, Black people, and Asians within a hospital-based population. Eur J Neurol 2009; 16:522.
  16. Rockman CB, Hoang H, Guo Y, et al. The prevalence of carotid artery stenosis varies significantly by race. J Vasc Surg 2013; 57:327.
  17. Arboix A, Alio J. Acute cardioembolic cerebral infarction: answers to clinical questions. Curr Cardiol Rev 2012; 8:54.
  18. Witt BJ, Brown RD Jr, Jacobsen SJ, et al. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med 2005; 143:785.
  19. Yaghi S, Pilot M, Song C, et al. Ischemic Stroke Risk After Acute Coronary Syndrome. J Am Heart Assoc 2016; 5.
  20. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765.
  21. Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827.
  22. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265:3255.
  23. Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757.
  24. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903.
  25. Seshadri S, Wolf PA, Beiser A, et al. Elevated midlife blood pressure increases stroke risk in elderly persons: the Framingham Study. Arch Intern Med 2001; 161:2343.
  26. Song YM, Sung J, Lawlor DA, et al. Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study. BMJ 2004; 328:324.
  27. Markidan J, Cole JW, Cronin CA, et al. Smoking and Risk of Ischemic Stroke in Young Men. Stroke 2018; 49:1276.
  28. Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res 2017; 120:472.
  29. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993; 269:232.
  30. Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, et al. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology 2004; 62:1558.
  31. Janghorbani M, Hu FB, Willett WC, et al. Prospective study of type 1 and type 2 diabetes and risk of stroke subtypes: the Nurses' Health Study. Diabetes Care 2007; 30:1730.
  32. Arenillas JF, Molina CA, Chacón P, et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63:27.
  33. Baldassarre D, Tremoli E, Franceschini G, et al. Plasma lipoprotein(a) is an independent factor associated with carotid wall thickening in severely but not moderately hypercholesterolemic patients. Stroke 1996; 27:1044.
  34. Peltier M, Iannetta Peltier MC, Sarano ME, et al. Elevated serum lipoprotein(a) level is an independent marker of severity of thoracic aortic atherosclerosis. Chest 2002; 121:1589.
  35. McEvoy AW, Kitchen ND, Thomas DG. Lesson of the week: intracerebral haemorrhage in young adults: the emerging importance of drug misuse. BMJ 2000; 320:1322.
  36. Toossi S, Hess CP, Hills NK, Josephson SA. Neurovascular complications of cocaine use at a tertiary stroke center. J Stroke Cerebrovasc Dis 2010; 19:273.
  37. Bhattacharya P, Taraman S, Shankar L, et al. Clinical profiles, complications, and disability in cocaine-related ischemic stroke. J Stroke Cerebrovasc Dis 2011; 20:443.
  38. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000; 343:1826.
  39. Oral contraceptives and stroke in young women. Associated risk factors. JAMA 1975; 231:718.
  40. Chaturvedi S, Adams HP Jr, Woolson RF. Circadian variation in ischemic stroke subtypes. Stroke 1999; 30:1792.
  41. Bladin CF, Alexandrov AV, Bellavance A, et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57:1617.
  42. Szaflarski JP, Rackley AY, Kleindorfer DO, et al. Incidence of seizures in the acute phase of stroke: a population-based study. Epilepsia 2008; 49:974.
Topic 1134 Version 24.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟